-
2018CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis, J. Mol. Biol. 2018 Aug;430(17):2557-2589.
-
2018CD4 T cell-mediated HLA class II cross-restriction in HIV controllers, Sci Immunol 2018 06;3(24).
-
2018A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers, MBio 2018 May;9(3).
-
2017DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers, J. Immunol. 2017 Nov;199(10):3437-3452.
-
2017Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A, Sci Rep 2017 Feb;7:42902.
-
2017Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response, Proc. Natl. Acad. Sci. U.S.A. 2017 Feb;114(9):2319-2324.
-
2016Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins, J. Virol. Methods 2016 Oct;236:184-95.
-
2016Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4, Sci Signal 2016 Nov;9(452):ra107.
-
2016Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions, Retrovirology 2016 Jul;13(1):50.
-
2016Public T cell receptors confer high-avidity CD4 responses to HIV controllers, J. Clin. Invest. 2016 Apr;.
-
2016TCR clonotypes: molecular determinants of T-cell efficacy against HIV, Curr Opin Virol 2016 Feb;16:77-85.
-
2015A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity, Retrovirology 2015;12:50.
-
2015SDF-1/CXCL12: A Chemokine in the Life Cycle of HIV, Front Immunol 2015;6:256.
-
2015Recognition determinants of broadly neutralizing human antibodies against dengue viruses., Nature 2015 Apr; 520(7545): 109-13.
-
2015[IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV], Med Sci (Paris) 2015 Jan;31(1):53-9.
-
2014B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis, J. Autoimmun. 2015 Jan;56:1-11.
-
2014The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo, Emerg Microbes Infect 2014 Sep;3(9):e62.
-
2014Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS 2014 Jul;28(11):1593-602.
-
2014Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry, J. Biol. Chem. 2014 Jul;289(27):19042-52.
-
2013Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles, J. Virol. 2013 Sep;87(18):10368-80.
-
2013HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines, Proc. Natl. Acad. Sci. U.S.A. 2013 Jun;110(23):9475-80.
-
2013Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia, PLoS ONE 2013;8(1):e55570.
-
2012Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions, Circulation 2012 Oct;126(15):1882-95.
-
2012HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term, J. Virol. 2012 Oct;86(19):10661-74.
-
2012Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody, Structure 2012 Feb;20(2):303-14.
-
2011HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization, AIDS 2011 Sep;25(15):1843-53.
-
2011IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis, PLoS ONE 2011;6(8):e23185.
-
2011HIV controllers: a multifactorial phenotype of spontaneous viral suppression, Clin. Immunol. 2011 Oct;141(1):15-30.
-
2011CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory, PLoS ONE 2011;6(4):e18726.
-
2011[Role of CD4 lymphocytes in the efficient immune response of HIV controllers], Bull. Acad. Natl. Med. 2011 Mar;195(3):545-57; discussion 557-9.
-
2010A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome, Cell Host Microbe 2010 Dec;8(6):523-33.
-
2010New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection, J. Biol. Chem. 2011 Feb;286(7):4978-90.
-
2010Immune mechanisms of HIV control, Curr. Opin. Immunol. 2010 Aug;22(4):488-96.
-
2010Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis, Am. J. Respir. Crit. Care Med. 2010 Sep;182(6):774-83.
-
2010HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity, PLoS Pathog. 2010 Feb;6(2):e1000780.
-
2010Type I IFN controls chikungunya virus via its action on nonhematopoietic cells., J Exp Med 2010 Feb; 207(2): 429-42.
-
2010Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway, J. Virol. 2010 Jan;84(1):96-108.
-
2009Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4, Blood 2010 May;115(18):3708-17.
-
2009IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema, J. Immunol. 2009 Dec;183(12):8195-202.
-
2009A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry, Nat. Chem. Biol. 2009 Oct;5(10):743-8.
-
2009HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression, AIDS 2009 Jun;23(10):1197-207.
-
2009A programmed switch from IL-15- to IL-2-dependent activation in human NK cells, J. Immunol. 2009 May;182(10):6267-77.
-
2009CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling, Blood 2009 Jun;113(24):6085-93.
-
2009Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis, Am. J. Respir. Crit. Care Med. 2009 May;179(10):903-13.
-
2008The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins, PLoS ONE 2008;3(7):e2543.
-
2008Small neutralizing molecules to inhibit actions of the chemokine CXCL12, J. Biol. Chem. 2008 Aug;283(34):23189-99.
-
2008CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome, Blood 2008 Jul;112(1):34-44.
-
2008Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling, J. Clin. Invest. 2008 Mar;118(3):1074-84.
-
2008A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease., PLoS Pathog 2008 Feb; 4(2): e29.
-
2007Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury, Int J Exp Pathol 2007 Dec;88(6):387-91.
-
2007IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice, J. Clin. Invest. 2007 Dec;117(12):3786-99.
-
2007Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study, J. Virol. 2007 Dec;81(24):13904-15.
-
2007Long oligonucleotide microarrays for African green monkey gene expression profile analysis., FASEB J 2007 Oct; 21(12): 3262-71.
-
2007Identification of a postendocytic sorting sequence in CCR5, Mol. Pharmacol. 2007 Dec;72(6):1497-507.
-
2007Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure, Virology 2007 Oct;367(1):196-211.
-
2007Characterization of reemerging chikungunya virus, PLoS Pathog. 2007 Jun;3(6):e89.
-
2007The C type lectins DC-SIGN and L-SIGN: receptors for viral glycoproteins, Methods Mol. Biol. 2007;379:51-68.
-
2006Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks, Retrovirology 2006;3:81.
-
2006Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands, Semin. Immunol. 2006 Dec;18(6):387-403.
-
2006Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells, J. Virol. 2006 Mar;80(6):2949-57.
-
2005The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes, J. Biol. Chem. 2005 Oct;280(42):35760-6.
-
2005On the dimerization of CCR5, Nat. Immunol. 2005 Jun;6(6):535; author reply 535-6.
-
2005Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E, J. Gen. Virol. 2005 May;86(Pt 5):1423-34.
-
2005Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals, J. Biol. Chem. 2005 Jun;280(25):23698-708.
-
2005Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis, Mol. Pharmacol. 2005 Jun;67(6):1966-76.
-
2004Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation, J. Biol. Chem. 2005 Feb;280(8):6692-700.
-
2004CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes, J. Immunol. 2004 Dec;173(12):7150-60.
-
2004WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, Blood 2005 Mar;105(6):2449-57.
-
2004The composition of the beta-2 adrenergic receptor oligomer affects its membrane trafficking after ligand-induced endocytosis, Mol. Pharmacol. 2005 Jan;67(1):288-97.
-
2004C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles, J. Biol. Chem. 2004 Jul;279(31):32035-45.
-
2004The paradox of simian immunodeficiency virus infection in sooty mangabeys: active viral replication without disease progression, Front. Biosci. 2004 Jan;9:521-39.
-
2003Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system, Glia 2003 Apr;42(2):139-48.
-
2003DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2, J. Biol. Chem. 2003 May;278(22):20358-66.
-
2003G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates, J. Virol. 2003 Feb;77(4):2550-8.
-
2003A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication, J. Virol. 2003 Jan;77(2):1245-56.
-
2002Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells, AIDS 2002 Nov;16(17):2337-40.
-
2002HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains, J. Biol. Chem. 2003 Jan;278(5):3153-61.
-
2002Interaction of HIV-1 integrase with DNA repair protein hRad18, J. Biol. Chem. 2002 Jul;277(30):27489-93.
-
2002Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4, J. Biol. Chem. 2002 May;277(18):15677-89.
-
2002Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones, J. Virol. 2002 Feb;76(4):1588-99.
-
2001Antigenically distinct conformations of CXCR4, J. Virol. 2001 Oct;75(19):8957-67.
-
2001A divergent simian immunodeficiency virus from sooty mangabey with an atypical Tat-TAR structure, AIDS Res. Hum. Retroviruses 2001 Aug;17(12):1155-65.
-
2001Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor, J. Virol. 2001 Jun;75(12):5457-64.
-
2001HIV-1 entry and how to block it, AIDS 2001;15 Suppl 5:S3-11.
-
2001Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay, J. Virol. 2001 Jan;75(1):251-9.
-
2000Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate, J. Biol. Chem. 2000 Nov;275(45):35137-45.
-
2000Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities, J. Biol. Chem. 2000 Aug;275(31):23736-44.
-
2000Age-dependent changes in T cell homeostasis and SIV load in sooty mangabeys, J. Med. Primatol. 2000 Aug;29(3-4):158-65.
-
2000Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection, J. Virol. 2000 Feb;74(3):1209-23.
-
1999Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses, J. Virol. 1999 Apr;73(4):2576-86.
-
1998The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus, J. Virol. 1998 Aug;72(8):6475-81.
-
1998Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100, J. Virol. 1998 Aug;72(8):6381-8.
-
1998The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2, J. Gen. Virol. 1998 Jul;79 ( Pt 7):1793-9.
-
1998Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease, J. Virol. 1998 May;72(5):3872-86.
-
1997Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice, Vaccine 1997 Dec;15(17-18):1946-54.
-
1997HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4, J. Immunol. 1997 Sep;159(6):3000-8.
-
1997Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry, Science 1997 Jun;276(5320):1874-8.
-
1997Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity, J. Virol. 1997 Jun;71(6):4744-51.
-
1996Interferon-gamma expression in macaque lymph nodes during primary infection with simian immunodeficiency virus, Cytokine 1996 Nov;8(11):844-52.
-
1996The relationship between the interferon alpha response and viral burden in primary SIV infection, AIDS Res. Hum. Retroviruses 1996 Sep;12(13):1273-8.
-
1996Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection, Res. Virol. 1996 Mar-Jun;147(2-3):181-9.
-
1996Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein, J. Virol. Methods 1996 Feb;56(2):179-89.
-
1995Low susceptibility of resident microglia to simian immunodeficiency virus replication during the early stages of infection, Neuropathol. Appl. Neurobiol. 1995 Dec;21(6):535-9.
-
1995Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus, Virology 1995 Nov;213(2):535-48.
-
1995Highly attenuated SIVmac142 is immunogenic but does not protect against SIVmac251 challenge, AIDS Res. Hum. Retroviruses 1995 Nov;11(11):1397-406.
-
1994Early stages of feline immunodeficiency virus infection in lymph nodes and spleen, AIDS Res. Hum. Retroviruses 1994 Dec;10(12):1731-8.
-
1994Cytokine patterns in lymph nodes during the early stages of simian immunodeficiency virus infection, Res. Immunol. 1994 Oct-Dec;145(8-9):702-5.
-
1994Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression, J. Virol. 1994 Oct;68(10):6634-43.
-
1994Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice, J. Gen. Virol. 1994 Jul;75 ( Pt 7):1569-78.
-
1994Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells, Am. J. Pathol. 1994 Jun;144(6):1226-37.
-
1994Early events in lymph nodes during infection with SIV and FIV, Res. Virol. 1994 May-Aug;145(3-4):221-7.
-
1994Kinetics of primary SIV infection in lymph nodes, J. Med. Primatol. 1994 Feb-May;23(2-3):117-24.
-
1993Target cells during early SIV encephalopathy, Res. Virol. 1993 Jan-Feb;144(1):41-6.
-
1992Comparison of early and late feline immunodeficiency virus encephalopathies, AIDS 1992 Apr;6(4):399-406.
-
1991Early viral replication in the brain of SIV-infected rhesus monkeys, Am. J. Pathol. 1991 Dec;139(6):1273-80.
-
1991Early SIV encephalopathy, J. Med. Primatol. 1991 Jun;20(4):159-66.
-
1989The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity, J. Virol. 1989 Oct;63(10):4395-403.
-
1987Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses, Nature 1987 Aug 6-12;328(6130):543-7.